3,359 findings · Energy balance · published 2017+
- Energy balanceStrong
There have been some adjustments in weight reduction medications available on the German market in the last two years.
Stay updated on the latest weight reduction medications available in Germany.
Supports 2022 - Energy balanceStrong
The article provides an outlook on new weight reduction medications that are about to be approved or are currently in Phase 3 of approval studies.
Be aware of new medications that may soon be available for weight reduction.
Supports 2022 - Energy balanceStrong
There are challenges to the use of GLP-1 RAs, including drug expense and availability.
Healthcare providers should be aware of the barriers to access when prescribing GLP-1 RAs.
Qualifies 2024 - Energy balanceStrong
The article provides an overview of available GLP-1 RAs, their mechanisms of action, indications, adverse reactions, and risks.
Providers can refer to this overview for practical information on GLP-1 RAs.
Supports 2024 - Energy balanceStrong
NHB participants reported higher perceived discrimination, sleep disturbance, and perceived stress than H and NHW participants at all time points.
Addressing psychosocial factors is crucial for improving surgical outcomes in NHB patients.
Supports 2025New - Energy balanceStrong
There may be a potential causal relationship between tirzepatide and vitreous hemorrhage in nondiabetic patients.
Caution is advised when prescribing tirzepatide, especially in nondiabetic patients.
Qualifies 2026New - Energy balanceStrong
A better healthcare provision for obesity treatment will initially burden the healthcare system but is expected to lead to a reduction in the obesity epidemic and cost savings in the long term.
Practitioners should prepare for initial challenges in the healthcare system while advocating for long-term benefits.
Supports 2024 - Energy balanceStrong
A broad societal consensus is crucial for implementing measures to reduce obesogenic living conditions.
Practitioners should engage with community efforts to create healthier environments.
Supports 2024 - Energy balanceStrong
Emerging clinical trials support the potential of GLP-1 receptor agonists in reversing cancer risk.
Practitioners should stay updated on clinical trial results regarding GLP-1 agonists and cancer risk.
Supports 2025New - Energy balanceStrong
Dietary supplements are generally safe, but their regulation is less stringent than for medicines.
Practitioners should ensure patients are aware of the regulatory status of dietary supplements.
Supports 2025New - Energy balanceStrong
A 10% energy surplus did not result in a significant change in body protein mass (0.00 kg; 95% CI, -0.38-0.39 kg; P = 0.980).
A modest increase in energy intake may not be sufficient to promote body protein mass gain.
Refutes 2024 - Energy balanceStrong
Protein supplementation does not seem to provide further improvements in untrained and healthy subjects.
Practitioners should consider the training status of individuals when recommending protein supplementation.
Refutes 2023 - Energy balanceStrong
The prevalence of any remission in the plate model was 27.1% during the first 2 years, decreasing over time.
The plate model may initially improve diabetes remission rates, but these rates decline over time.
Supports 2023 - Energy balanceStrong
Counselors spent less time providing feedback on participant self-monitoring data over the course of the study, decreasing from a mean of 53 minutes to 26 minutes.
Counselors can improve efficiency in providing feedback over time, which may reduce costs in technology-based weight loss interventions.
Supports 2020 - Energy balanceStrong
Counselors may be increasing their efficiency in providing feedback over time.
Counselors should focus on developing skills that enhance feedback efficiency over time.
Qualifies 2020 - Energy balanceStrong
People in Northern China often consume more plant-based foods.
Understanding local dietary habits can inform nutritional guidance and interventions.
Supports 2025New - Energy balanceStrong
The study will carry out meta-regression to determine the influence of moderator variables on findings.
Understanding moderator variables can help tailor training programs more effectively.
Supports 2021 - Energy balanceStrong
At the lowest income level, the proportions of individuals in the best carbohydrate quality category reduced from 26.9% to 20.6%.
Practitioners should be aware that lower income is associated with reduced dietary quality in carbohydrates.
Refutes 2023 - Energy balanceStrong
At the highest income level, the proportions of individuals in the best carbohydrate quality category increased from 22.9% to 26.6%.
Practitioners should recognize that higher income is associated with improved dietary quality in carbohydrates.
Supports 2023 - Energy balanceStrong
No significant differences were observed between the 4-6 RPE and 7-9 RPE groups for relative intensity or relative volume.
Training intensity and volume were similar between the two RPE groups, suggesting flexibility in training approaches.
Supports 2022 - Energy balanceStrong
No significant group × time interactions were observed between the two training protocols.
Both training approaches yield similar results, allowing flexibility in training intensity without compromising strength gains.
Refutes 2022 - Energy balanceStrong
Trivial between-group effect sizes were observed when comparing the strength gains of the 4-6 RPE group to the 7-9 RPE group (g = -0.12).
The similarity in strength gains suggests that both training intensities may be equally effective for improving squat strength.
Supports 2023 - Energy balanceStrong
The findings regarding back squat strength improvements between resistance training with 4-6 RPE and 7-9 RPE are statistically inconclusive.
Further research may be needed to clarify the effectiveness of different RPE levels in resistance training.
Qualifies 2023 - Energy balanceStrong
Meals in the bottom versus top half of glycemic responses ranked by Abbott resulted in 50±10% less glycemic reduction compared to Dexcom.
Meal planning should account for differences in CGM readings to optimize glycemic control.
Supports 2019